Healthcare News

Coronavirus Drug Remdesivir Price Climbs To $2,340 Per Patient

Written by David Miller

Gilead Sciences will distribute remdesivir as a coronavirus drug at $2,340 per patient and the U.S. is expected to be the first country to get most of the company's supply.Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]